Correlation Between Ameriprise Financial and Grace Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Ameriprise Financial and Grace Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ameriprise Financial and Grace Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ameriprise Financial and Grace Therapeutics,, you can compare the effects of market volatilities on Ameriprise Financial and Grace Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ameriprise Financial with a short position of Grace Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ameriprise Financial and Grace Therapeutics,.
Diversification Opportunities for Ameriprise Financial and Grace Therapeutics,
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Ameriprise and Grace is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Ameriprise Financial and Grace Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Grace Therapeutics, and Ameriprise Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ameriprise Financial are associated (or correlated) with Grace Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Grace Therapeutics, has no effect on the direction of Ameriprise Financial i.e., Ameriprise Financial and Grace Therapeutics, go up and down completely randomly.
Pair Corralation between Ameriprise Financial and Grace Therapeutics,
Considering the 90-day investment horizon Ameriprise Financial is expected to generate 0.33 times more return on investment than Grace Therapeutics,. However, Ameriprise Financial is 3.07 times less risky than Grace Therapeutics,. It trades about 0.08 of its potential returns per unit of risk. Grace Therapeutics, is currently generating about 0.02 per unit of risk. If you would invest 32,337 in Ameriprise Financial on October 4, 2024 and sell it today you would earn a total of 20,906 from holding Ameriprise Financial or generate 64.65% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Ameriprise Financial vs. Grace Therapeutics,
Performance |
Timeline |
Ameriprise Financial |
Grace Therapeutics, |
Ameriprise Financial and Grace Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ameriprise Financial and Grace Therapeutics,
The main advantage of trading using opposite Ameriprise Financial and Grace Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ameriprise Financial position performs unexpectedly, Grace Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Grace Therapeutics, will offset losses from the drop in Grace Therapeutics,'s long position.Ameriprise Financial vs. State Street Corp | Ameriprise Financial vs. Bank of New | Ameriprise Financial vs. SEI Investments | Ameriprise Financial vs. Principal Financial Group |
Grace Therapeutics, vs. Vaccinex | Grace Therapeutics, vs. Vigil Neuroscience | Grace Therapeutics, vs. Viracta Therapeutics | Grace Therapeutics, vs. Dogwood Therapeutics, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |